Shao-Chun Chang

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn et al. · The Lancet Oncology · 2015 · 938 citations

Oncology, Colorectal Cancer, Pathology +7

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Andrew X. Zhu, Joon Oh Park, Baek‐Yeol Ryoo et al. · The Lancet Oncology · 2015 · 829 citations · Full text

Oncology, Hepatology, Clinical Trials +10

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Eileen M. O’Reilly, Do‐Youn Oh, Neesha C. Dhani et al. · JAMA Oncology · 2019 · 722 citations · Full text

Isolation and Characterization of the Gene (CLS1 ) Encoding Cardiolipin Synthase in Saccharomyces cerevisiae

Shao-Chun Chang, Philip Heacock, Eugenia Mileykovskaya et al. · Journal of Biological Chemistry · 1998 · 212 citations · Full text

The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases

Alexander Ungewickell, Christopher Hugge, Marina V. Kisseleva et al. · Proceedings of the National Academy of Sciences · 2005 · 124 citations · Full text